551
Participants
Start Date
December 31, 2012
Primary Completion Date
September 1, 2016
Study Completion Date
November 9, 2016
Multispectral Digital Colposcope (MDC)
"The MDC has 2 components: an optical probe \& a multispectral colposcope. The optical wand makes use of fluorescence \& reflectance spectroscopy; a light is shone on the cervix and the wand reports what it sees to a computer. Since cancer \& healthy cells interact differently with light, a computer can detect abnormalities. The multispectral colposcope is based on a conventional colposcope, which is already widely used. However, it is also able to produce fluorescence \& polarized reflectance images of the entire cervix. Computer analysis of these images can detect abnormalities on the cervix, defining their location and shape.~This trial involves combined analysis of MDC data. This may lead to more effective diagnosis of cervical abnormalities. The MDC will be used with standard care for patients presenting with cervical abnormalities (as detected by a Pap test). The MDC will not be used to guide patient management decisions.~All study subjects will receive this same intervention."
Brookdale Hospital and Medical Center, Brooklyn
Texas Tech Health Sciences Center, El Paso
Vancouver General Hospital - Women's Clinic (G&L Diamond Centre), Vancouver
National Cancer Institute (NCI)
NIH
Texas Tech University Health Sciences Center
OTHER
Brookdale University Hospital Medical Center
OTHER
William Marsh Rice University
OTHER
The University of Texas Health Science Center, Houston
OTHER
M.D. Anderson Cancer Center
OTHER
British Columbia Cancer Agency
OTHER